Jacobs Levy Equity Management’s Intermolecular, Inc. IMI Stock Holding History

Jacobs Levy Equity Management’s Portfolio IMI Stock Details IMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-84,345	Closed	-$78K	–	1062
2017 Q1	$78K	Hold	84,345	–	–	﹤0.01%	872
2016 Q4	$80K	Hold	84,345	–	–	﹤0.01%	922
2016 Q3	$84K	Sell	84,345 -6,000	-7%	-$7.39K	﹤0.01%	972
2016 Q2	$134K	Buy	+90,345	New	+$182K	﹤0.01%	1065
2016 Q1	–	Sell	-26,500	Closed	-$61K	–	1211
2015 Q4	$61K	Hold	26,500	–	–	﹤0.01%	772
2015 Q3	$50K	Sell	26,500 -32,000	-55%	-$67K	﹤0.01%	787
2015 Q2	$115K	Sell	58,500 -11,827	-17%	-$21.9K	﹤0.01%	760
2015 Q1	$115K	Hold	70,327	–	–	﹤0.01%	740
2014 Q4	$136K	Sell	70,327 -51,562	-42%	-$110K	﹤0.01%	766
2014 Q3	$283K	Buy	+121,889	New	+$279K	﹤0.01%	689

Other funds holding IMI

RCM

Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return

SPM

Symmetry Peak Management Radnor, Pennsylvania $369M AUM 148.4% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

SIM

Spark Investment Management New York $51.2M AUM 87.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jacobs Levy Equity Management's IMI Position: Q2 2017 in Review

Jacobs Levy Equity Management sold out of Intermolecular, Inc. (IMI) in Q2 2017, closing a stake of 84,345 shares — an estimated $78K sold.

Jacobs Levy Equity Management first reported a position in IMI in Q3 2014 and held it in 10 quarters. The position peaked at $283K in Q3 2014. 23 funds tracked by Wall St. Rank hold IMI as of Q2 2017.

Jacobs Levy Equity Management reported no remaining Intermolecular, Inc. position as of Q2 2017 after selling out during the quarter.
Jacobs Levy Equity Management sold 84,345 Intermolecular, Inc. shares in Q2 2017, an estimated $78K.
Jacobs Levy Equity Management first reported a position in Intermolecular, Inc. in Q3 2014 and held it in 10 quarters.
Jacobs Levy Equity Management's Intermolecular, Inc. position peaked at $283K in Q3 2014.
23 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q2 2017.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2017, filed 14 Aug 2017.